BLBS102-c42 BLBS102-Simpson March 21, 2012 14:27 Trim: 276mm X 219mm Printer Name: Yet to Come
804 Part 8: Food Safety and Food Allegens
allergy is the most commonly occurring food hypersensitivity
with symptoms usually becoming evident in the child’s first year.
Major Egg Allergens
Egg white is more allergenic than the egg yolk. Ovalbumin and
ovocumoid, the two most potent egg allergens together make
up about 65% of the composition of egg white proteins. Oval-
bumin has a MW of 44.5 kDa and contains 385 amino acids.
Using pooled sera from 18 egg-allergic patients, Mine and Rupa
(2003) identified five IgE binding linear epitopes in the primary
structure of the protein. Four of the five epitopes were exposed
at the surface of the protein.
Ovomucoid, the other major allergen, is a 28 kDa MW protein
comprising 186 amino acids. The protein has three structurally
distinct domains (Domain I, II and III), which are cross-linked
by disulfide bonds. Several linear sequences representing aller-
genic epitopes recognised by both IgE and IgG antibodies have
been identified (Zhang and Mine 1998, Mine and Zhang 2002).
Ovomucoid also contains 20–25% carbohydrate moieties. Most
reports indicate that the carbohydrate moieties are not immuno-
genic; however, some studies suggest that the carbohydrate re-
gion in the third domain is immunologically active (Mine and
Rupa 2004). Ovomucoid is relatively stable to digestion, and
heat and allergenic fragments have been detected even after di-
gestion by pepsin.
Other reported egg allergens are ovotransferrin (MW 76 kDa)
and lysozyme (MW 14.3 kDa). Aabin et al. (1996) reported
a higher frequency of reactivity for ovotransferrin (53%) than
for ovomucoid (38%) and ovalbumin (32%), suggesting that it
may be a more important allergen than the latter two. The same
authors reported frequency of reactivity of 15% for lysozyme.
Very few studies have reported on the allergenicity of egg yolk
proteins; however, some of the allergenic proteins identified in
egg yolk include apovitellenin I, apovitellenin VI and phosvitin
(Walsh et al. 1988, 2005).
Thresholds of Clinical Reactivity to Eggs
Reported thresholds of clinical reactivity to eggs range between
0.13 and 6.5 mg of hen’s egg protein (Morisset et al. 2003a,
Taylor et al. 2004). As with other allergens, there are currently
no cures for egg allergy, and the best management tool is the
reading of food labels and avoidance of foods containing egg
or egg-derived ingredients. The use of multiple definitions for
eggs and egg ingredients (e.g. albumin, albumen, conalbumin,
egg nog, egg yolk, egg white, lecithin, livetin, lysozyme, oval-
bumin, ovoglobulin, ovomacroglobulin, ovomucin, ovomucoid,
ovomucin, ovovitellin, ovotransferrin and vitellin) in the past
made egg avoidance challenging. Today, most countries in North
America as well as in Europe require the use of the common
names of priority allergens when they are used as ingredients in
foods or are likely to be present in foods in spite of best efforts
to control their presence. Fortunately, most children outgrow
their egg allergy by school age (Heine et al. 2006). Egg allergy,
however, tends to persist in children with positive skin tests,
multiple allergies and/or who have more severe reactions (e.g.
respiratory symptoms, angiodema and multisystemic reactions)
or other atopic diseases such as asthma (Ford and Taylor 1982,
Mine and Yang 2008).
SOYA BEAN ALLERGENS
Soya bean (Glycine max) is a legume belonging to thefabaceae
family and theglycinegenus. On a dry basis, soya beans contain
35–40% protein, 17–23% lipid, 31% carbohydrate and 4–5%
minerals. Soya bean is considered as one of the most nutritional
plant sources of food providing a well-balanced amino acid
profile and good supplies of omega 3 and omega 6 fatty acids.
The history of the seed dates as far back as 3000–5000 years,
with its origins somewhere in Asia.
Consumption of soya bean and soya bean foods has been
linked to many health benefits. Various studies have reported as-
sociations between soya bean consumption and reduced risk
of cardiovascular disease, cancer, diabetes, bone loss and
menopausal symptoms amongst others (Friedman and Brandon
2001, Hori et al. 2001, Chen et al. 2003, Zhang et al. 2003,
Stephenson et al. 2005, Anderson 2008). These reports have fu-
elled the growth of soya foods in Western countries. In October
1999, the Food and Drug Administration of the United States
approved a health claim linking the consumption of 25 grams
of soya protein a day (as part of a diet low in saturated fatty
acids) to reduced cardiovascular disease risk (FDA 1999). For
manufacturers to make this claim, products must provide at least
6.25 grams of soya protein per serving. Soya flour and soya pro-
tein ingredients are therefore increasingly being used in many
food products.
Unfortunately, soya bean is listed in Canada, the United States,
Australia and the European Union as a priority allergen, requir-
ing labelling when it is used as an ingredient in foods. Symp-
toms of soya bean allergy are similar to the other major allergens
and include cutaneous, respiratory as well as gastrointestinal re-
sponses. Although the majority of allergic responses occur on
ingestion, allergic reactions on inhalation of soya bean and soya
bean byproducts has also been reported (Gonzalez et al. 1992,
1995, Codina et al. 1997).
Major Soya Allergens
Over 17 different allergens have been identified in soya bean.
These include soya bean glycinin (11S),β-conglycinin (7S),
soya bean vacuolar protein (Gly m Bd 30K or P34), the Kunitz
trypsin inhibitor (KTI), Gly m Bd 28K, soya bean profilin
(Gly m 3), soya bean hull proteins (Gly m 1.0101, Gly m
1.0102, Gly m 2) and the pathogensis-related (PR) soya bean
protein SAM22 (Gly m 4) (Wilson et al. 2005, L’Hocine and
Boye 2007, Boye et al. 2010).
Glycinin andβ-conglycinin have been studied extensively
as they are the major soya bean storage proteins and repre-
sent over 70% of the proteins found in soya (Liu 1997). They
are both globulins belonging to the cupin superfamily (Breit-
eneder and Radauer 2004) and have complex quaternary struc-
tures with conserved amino acid sequence homology. Glycinin